Addition of metastasis-directed therapy increases PFS in prostate cancer

by

The addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival for men with oligometastatic prostate cancer, according to a study published online April 6 in JAMA Oncology.

Leave A Comment

Your email address will not be published. Required fields are marked *